Sofiva Genomics Co.,Ltd. (TPEX:6615)

Sofiva Genomics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	80.75	112.08	96.81	119.81	214.99	188.85
Short-Term Investments	34.1	34.1	43.23	51.15	30.2	30.2
Cash & Short-Term Investments	114.85	146.18	140.03	170.96	245.19	219.05
Cash Growth	-6.94%	4.39%	-18.09%	-30.27%	11.94%	-10.58%
Accounts Receivable	61.96	65.94	75.95	75.16	74.04	62.32
Other Receivables	13.12	4.98	9.01	7.53	4.76	2.96
Receivables	75.08	70.92	84.96	82.68	78.8	65.28
Inventory	45.54	46.4	41.79	57.08	41.56	50.11
Prepaid Expenses	10.99	7.95	8.78	10.83	6.58	8.02
Other Current Assets	1.01	1.15	1.79	2.33	1.39	1.18
Total Current Assets	247.47	272.6	277.34	323.88	373.53	343.64
Property, Plant & Equipment	86.06	103.16	116.08	129.23	128.57	159.96
Long-Term Investments	375.23	368.02	348.09	333.32	297.35	229.74
Other Intangible Assets	9.38	8.19	6.86	6.61	6.23	3.78
Long-Term Deferred Tax Assets	8.63	5.06	9.31	6.65	8.91	8.58
Other Long-Term Assets	24.23	11.06	9.45	7.87	7.72	5.89
Total Assets	750.99	768.08	767.14	807.56	822.3	751.58
Accounts Payable	23.66	22.47	31.72	50.6	58.44	50.44
Accrued Expenses	-	33.1	37.15	36.48	30.52	31.01
Current Portion of Leases	16.6	16.43	14.43	14.16	14.48	15.45
Current Income Taxes Payable	0.85	-	-	-	4.22	-
Current Unearned Revenue	2.25	1.77	0.77	2.11	2.69	3.25
Other Current Liabilities	42	9.68	12.12	12.64	12.99	9.91
Total Current Liabilities	85.36	83.46	96.2	115.99	123.35	110.06
Long-Term Leases	28.61	36.95	49.15	60.52	71.45	85.65
Long-Term Deferred Tax Liabilities	0.17	0.24	0.25	0.62	-	0.02
Other Long-Term Liabilities	3.05	3.03	3.17	3.12	3.06	3.04
Total Liabilities	117.19	123.68	148.77	180.24	197.86	198.77
Common Stock	215.93	215.93	213.62	213.62	213.62	212.62
Additional Paid-In Capital	242.63	341.59	332.06	330.99	328.31	284.32
Retained Earnings	76.53	86.66	72.5	82.34	82.29	55.08
Comprehensive Income & Other	98.89	-0.15	-0.05	-0.03	0.01	0.34
Total Common Equity	633.99	644.04	618.14	626.92	624.23	552.36
Minority Interest	-0.18	0.36	0.23	0.4	0.21	0.45
Shareholders' Equity	633.8	644.4	618.37	627.32	624.44	552.81
Total Liabilities & Equity	750.99	768.08	767.14	807.56	822.3	751.58
Total Debt	45.22	53.38	63.59	74.67	85.94	101.1
Net Cash (Debt)	69.64	92.8	76.45	96.29	159.26	117.95
Net Cash Growth	3.08%	21.39%	-20.61%	-39.54%	35.02%	-15.32%
Net Cash Per Share	3.24	4.29	3.58	4.50	7.48	5.52
Filing Date Shares Outstanding	20.5	21.59	21.36	21.36	21.36	21.26
Total Common Shares Outstanding	20.5	21.59	21.36	21.36	21.36	21.26
Working Capital	162.11	189.14	181.14	207.89	250.18	233.58
Book Value Per Share	30.93	29.83	28.94	29.35	29.22	25.98
Tangible Book Value	624.6	635.85	611.28	620.3	618	548.58
Tangible Book Value Per Share	30.47	29.45	28.61	29.04	28.93	25.80
Machinery	-	167.48	157.43	144.6	115.73	107.69
Leasehold Improvements	-	28.15	28.33	29.91	29.33	29.55

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.